Emma Flett > Kirkland & Ellis International LLP > London, England > Lawyer Profile

Described as ‘one of the best teams in life sciences and healthcare in London’ Kirkland & Ellis International LLP advises a multitude of major life sciences companies on the global formulation and coordination of life science patent litigation strategy. Daniel Lim co-heads the practice and has a proven track record in pharmaceutical and medical device litigation. Fellow co-head Nicola Dagg is a known name for work including strategic patent and product lifecycle advice. Emma Flett completes the leadership team and is geared to advise on the of IP aspects of M&A transactions. SPC disputes relating to biologic and small molecule products are a practice strength of Steven Baldwin, while Jin Ooi works extensively on follow-on damages inquiry mandates.

Praised for its ‘unbeatable combination of experience, talent and tenacity’, Kirkland & Ellis International LLP operates for a consortium of notable clients in multi-faceted mandates that tackle complex issues such as SEP/FRAND and technically challenging M&A. Nicola Dagg helms the litigation side of the practice with her market traction in the most cutting-edge mandates, while Emma Flett, who leads the technology and transactional side of the practice, demonstrates a strong grounding in a litany of mandates, from private equity transactions and M&A to licensing and development issues. Daniel Lim is well positioned to represent clients in litigation that involves medical devices, SEP/FRAND, and blockbusters in the life sciences space. Steven Baldwin is notably active in the High Court, representing clients in relation to high-tech and life sciences issues. Another name to note is experienced litigator Jin Ooi, who is pre-eminent in the fields of life sciences and consumer products. Katie Coltart departed to Linklaters LLP in September 2023.